Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications (GLUTADIAB)
Sponsor: Assistance Publique - Hôpitaux de Paris
Listed as NCT04353869, this observational or N/A phase trial focuses on Cardiovascular Complications and Diabetic and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 12 times since 2020, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Apr 2025 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Dec 2023 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Apr 2022 — Sep 2022 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
May 2020 — Nov 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- National Research Agency, France
For direct contact, visit the study record on ClinicalTrials.gov .